Evidence map›Paper›PMID 37461124›Full record

ArticleThoracic cancer2023

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Qian Wang, Chunwei Xu, Wenxian Wang, Yongchang Zhang, Ziming Li, Zhengbo Song, Jiandong Wang, Jinpu Yu, Jingjing Liu, Shirong Zhang and 101 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Thoracic cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Recent Advances in Medical Treatment of Malignant Pleural Mesothelioma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

111 authors.

Qian WangDepartment of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Chunwei XuInstitute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.ORCID 0000-0002-9021-6731
Wenxian WangDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.ORCID 0000-0002-3047-4149
Yongchang ZhangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.ORCID 0000-0002-6829-7176
Ziming LiDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhengbo SongDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.ORCID 0000-0002-4817-7775
Jiandong WangDepartment of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Jinpu YuDepartment of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jingjing LiuDepartment of Thoracic Cancer, Jilin Cancer Hospital, Changchun, China.
Shirong ZhangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-9334-1637
Xiuyu CaiDepartment of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wen LiKey Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Ping ZhanDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0009-0001-3030-2662
Hongbing LiuDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0000-0003-1404-0647
Tangfeng LvDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0000-0001-7224-8468
Liyun MiaoDepartment of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0000-0001-9586-3244
Lingfeng MinDepartment of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, China.
Jiancheng LiDepartment of Radiation Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.
Baogang LiuDepartment of Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Jingping YuanDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhansheng JiangDepartment of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.ORCID 0000-0002-5707-5148
Gen LinDepartment of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.ORCID 0000-0001-9411-5519
Xiaohui ChenDepartment of Thoracic Surgery, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.
Xingxiang PuDepartment of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Chuangzhou RaoDepartment of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Dongqing LvDepartment of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
Zongyang YuDepartment of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, China.
Xiaoyan LiDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Chuanhao TangDepartment of Medical Oncology, Peking University International Hospital, Beijing, China.
Chengzhi ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.ORCID 0000-0003-0029-6879
Junping ZhangDepartment of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Hui GuoDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Qian ChuDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Rui MengCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xuewen LiuDepartment of Oncology, the Third Xiangya Hospital, Central South University, Changsha, China.
Jingxun WuDepartment of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, China.
Xiao HuZhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Jin ZhouDepartment of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, China.
Zhengfei ZhuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID 0000-0001-7537-3619
Xiaofeng ChenDepartment of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.
Weiwei PanDepartment of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, China.
Fei PangDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Wenpan ZhangDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Qijie JianDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Kai WangDepartment of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Liping WangDepartment of Oncology, Baotou Cancer Hospital, Baotou, China.
Youcai ZhuDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Guocai YangDepartment of Thoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.
Xinqing LinState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.ORCID 0000-0001-9436-2229
Jing CaiDepartment of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.ORCID 0000-0002-6792-4959
Huijing FengDepartment of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Lin WangDepartment of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Yingying DuDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID 0000-0002-5149-4632
Wang YaoDepartment of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xuefei ShiDepartment of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, China.
Xiaomin NiuDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Dongmei YuanDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yanwen YaoDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Jianhui HuangDepartment of Oncology, Lishui Municipal Central Hospital, Lishui, China.
Xiaomin WangDepartment of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, China.
Yinbin ZhangDepartment of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.
Pingli SunDepartment of Pathology, The Second Hospital of Jilin University, Changchun, China.
Hong WangSenior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, China.
Mingxiang YeDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Dong WangDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Zhaofeng WangDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yue HaoDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.ORCID 0000-0002-4725-6084
Zhen WangDepartment of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Bing WanDepartment of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Donglai LvDepartment of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, China.ORCID 0000-0003-4128-6853
Jianwei YuDepartment of Respiratory Medicine, Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi Province Hospital of Chinese Medicine, Nanchang, China.
Jin KangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Jiatao ZhangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Chao ZhangGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Lixin WuDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Lin ShiDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Leiguang YeDepartment of Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Gaoming WangDepartment of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Yina WangDepartment of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Feng GaoDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Jianfei HuangDepartment of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, China.
Guifang WangDepartment of Respiratory Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Jianguo WeiDepartment of Pathology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, China.
Long HuangDepartment of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.ORCID 0000-0003-4925-5162
Bihui LiDepartment of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Zhang ZhangInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China.
Zhongwu LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Yueping LiuDepartment of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yuan LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhefeng LiuSenior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, China.
Nong YangDepartment of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Lin WuDepartment of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Qiming WangDepartment of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wenbin HuangDepartment of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Zhuan HongDepartment of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Guansong WangInstitute of Respiratory Diseases, Xinjian Hospital, Third Military Medical University, Chongqing, China.
Fengli QuInstitute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.
Meiyu FangDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Yong FangDepartment of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Xixu ZhuDepartment of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Kaiqi DuDepartment of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Jiansong JiDepartment of Radiology, Lishui Municipal Central Hospital, Lishui, China.
Yi ShenDepartment of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0000-0002-2144-882X
Jing ChenCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yiping ZhangDepartment of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Shenglin MaDepartment of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.
Yuanzhi LuDepartment of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID 0000-0003-2946-643X
Yong SongDepartment of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.ORCID 0000-0003-4979-4131
Anwen LiuDepartment of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wenzhao ZhongGuangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.ORCID 0000-0002-8917-8635
Wenfeng FangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow-up.

Indexed as

Mesothelioma, MalignantPleural NeoplasmsChinaConsensusEast Asian PeopleHumansdiagnosismalignant pleural mesotheliomaprognosistreatment

Identifiers

PMID37461124
PMCPMC10493492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.